TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
OGN

Organon & Co

Healthcare · Drug Manufacturers - General

13.70$ +0.1% vs. previous close Closing price · As of: Sep 17, 2026

Filings

Filings

Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Organon & Co (OGN) with date, type and a link to the original document.

Filings OGN
Date Type Filing Original
08/14/2026 Ownership disclosure Form SC 13G filed with the SEC View document ↗
08/05/2026 Insider sale notice Form 144 filed with the SEC View document ↗
07/31/2026 Current report (8-K) Organon & Co. (OGN): Regulation FD Disclosure; Financial Statements and Exhibits View report ↗
07/23/2026 Current report (8-K) Organon & Co. (OGN): Submission of Matters to a Vote of Security Holders View report ↗
07/17/2026 Current report (8-K) Organon & Co. (OGN): Other Events View report ↗

Showing the 100 most recent filings of the selected type.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?